Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors

Name: Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
License: Public Domain

Emory University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent classic hodgkin lymphoma, refractory classic hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287551
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.